Aim Immunotech Inc. (AIM)

Market is closed

Sector: Biological Products, (No Disgnostic Substances)

Hedge Fund Popularity

Display

Display Share Price

Hedge Fund Holdings

Filing Period:

Last updated on February 17, 2026, 1:23pm based on SEC 13F filings Last update: February 17, 2026, 1:23pm

No.	Hedge Fund	Shares	Value	Activity	% Port
1.	Sabby Capital Hal Mintz	0	$0		0%

Insider Trading: Purchases See All

Insider	Price	Amount	Total Value	Remaining Holdings	Date	Form 4
Equels Officer, Director	$7.70	107	$823.58	38,885	2025-06-13	Filing
Equels Officer, Director	$8.70	103	$896.10	38,675	2025-06-12	Filing
Mitchell Director	$0.03	196,851	$5,000.02	521,723	2025-04-11	Filing
Equels Officer, Director	$0.03	1,968,504	$50,000.00	3,867,533	2025-04-11	Filing
Kellner Director	$0.03	1,968,504	$50,000.00	1,969,504	2025-04-11	Filing

Insider Trading: Sales See All

Insider	Price	Amount	Total Value	Remaining Holdings	Date	Form 4
Mitchell Director	$0.19	4,580	$883.94	118,549	2024-12-19	Filing
Carter Large Shareholder, Officer, Director	$0.50	1,129	$560.89	890,585	2010-08-10	Filing
Carter Large Shareholder, Officer, Director	$0.48	26,519	$12,755.64	889,570	2010-08-11	Filing
Carter Large Shareholder, Officer, Director	$0.49	224,110	$110,351.76	916,089	2010-08-10	Filing
Carter Large Shareholder, Officer, Director	$0.50	125,630	$63,066.26	1,140,199	2010-08-10	Filing

Institutional Investors' Holdings

Filing Period:

No.	Name	Shares	Value	% Port
1.	Jane Street Group, Llc	807,885	$229,439	0%
2.	Morgan Stanley	50,864	$14,445	0%
3.	Geode Capital Management, Llc	46,003	$13,064	0%
4.	Goldman Sachs Group Inc	32,444	$9,214	0%
5.	Ubs Group Ag	28,931	$8,216	0%